Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations

We have previously reported that sulindac, a non-steroidal anti-inflammatory drug, inhibited tumor formation in the small intestine but increased tumors in the colon of Apc(Min/)(+) mice, a model of human familial adenomatous polyposis. To further explore intestinal regional responses, we studied ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Itano, Osamu, Yang, Kan, Fan, Kunhua, Kurihara, Naoto, Shinozaki, Hiroharu, Abe, Sadanori, Jin, Bo, Gravaghi, Claudia, Edelmann, Winfried, Augenlicht, Leonard, Kopelovich, Levy, Kucherlapati, Raju, Lamprecht, Sergio, Lipkin, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2009
Assuntos:
Cancer Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783002/
https://ncbi.nlm.nih.gov/pubmed/19755659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgp200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados